Exact Sciences Announces Preliminary Fourth Quarter 2023 Results

DAK PRESCOTT JOINS RYAN REYNOLDS’ MAXIMUM EFFORT AND THE COLORECTAL CANCER ALLIANCE TO 'LEAD FROM BEHIND'

Exact Sciences Awards Grants to 23 Organizations Focused on Increasing Colorectal Cancer Screenings

Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and individualization of therapy for breast cancer patients

Exact Sciences Presents New Long-Term Patient Outcomes In Multi-Cancer Early Detection And Breast Cancer Recurrence Testing at ASCO^® 2023

Exact Sciences Files Patent Infringement Lawsuit Against Geneoscopy

Exact Sciences Announces Third-Quarter 2023 Results

Next-Generation Cologuard® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly outperforming fecal immunochemical testing (FIT) for cancer and precancer detection

Exact Sciences Advances Early Cancer Detection and Precision Oncology Programs with Data Presentations at ESMO 2023 Annual Congress

Exact Sciences to Present Late-Breaking Data from Pivotal BLUE-C Study on Next-Generation Cologuard at ACG 2023

Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience

Exact Sciences Lab and OncoExTra Test Selected by National Cancer Institute for ComboMATCH Clinical TRIALs